107 related articles for article (PubMed ID: 6107564)
21. Dopamine and schizophrenia--proof at last?
Harrison PJ
Lancet; 2000 Sep; 356(9234):958-9. PubMed ID: 11041394
[No Abstract] [Full Text] [Related]
22. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
[TBL] [Abstract][Full Text] [Related]
23. Dopamine receptors and schizophrenia: the neuroleptic drug problem.
Reynolds GP; Riederer P; Jellinger K; Gabriel E
Neuropharmacology; 1981 Dec; 20(12B):1319-20. PubMed ID: 6119642
[No Abstract] [Full Text] [Related]
24. [Neuroleptics and dopamine. How the antipsychotic breakthrough resulted in improved knowledge about the biology of schizophrenia].
Fog R
Ugeskr Laeger; 2000 Jan; 162(1):68-9. PubMed ID: 10658506
[No Abstract] [Full Text] [Related]
25. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.
Brody AL; Mandelkern MA; Olmstead RE; Scheibal D; Hahn E; Shiraga S; Zamora-Paja E; Farahi J; Saxena S; London ED; McCracken JT
Arch Gen Psychiatry; 2006 Jul; 63(7):808-16. PubMed ID: 16818870
[TBL] [Abstract][Full Text] [Related]
26. Changes in cerebral dopamine metabolism and receptors during one-year neuroleptic administration and subsequent withdrawal: relevance to brain biochemistry in schizophrenia.
Clow A; Jenner P; Theodorou A; Marsden CD
Adv Biochem Psychopharmacol; 1980; 24():53-5. PubMed ID: 6105799
[No Abstract] [Full Text] [Related]
27. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
Lideman RR; Zlobina GP; Mukhin AG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
[No Abstract] [Full Text] [Related]
28. Dopaminergic synapses in the caudate of subjects with schizophrenia: relationship to treatment response.
Roberts RC; Roche JK; Conley RR; Lahti AC
Synapse; 2009 Jun; 63(6):520-30. PubMed ID: 19226604
[TBL] [Abstract][Full Text] [Related]
29. [Specific binding of 3H-domperidone--a selective ligand of D2-dopamine receptors--by the human caudate nucleus].
Zlobina GP; Chekalina ND
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(7):1043-5. PubMed ID: 2960110
[TBL] [Abstract][Full Text] [Related]
30. Dopamine receptors and schizophrenia: drug effect or illness.
Reynolds GP; Reynolds LM; Riederer P; Jellinger K; Gabriel E
Lancet; 1980 Dec; 2(8206):1251. PubMed ID: 6108424
[No Abstract] [Full Text] [Related]
31. [3H] GBR 12935 binding to the dopamine uptake site in post-mortem brain tissue in schizophrenia.
Czudek C; Reynolds GP
J Neural Transm; 1989; 77(2-3):227-30. PubMed ID: 2760605
[TBL] [Abstract][Full Text] [Related]
32. Dopaminergic abnormalities in postmortem schizophrenic brain.
Mackay AV; Bird ED; Iversen LL; Spokes EG; Creese I; Snyder SH
Adv Biochem Psychopharmacol; 1980; 24():325-33. PubMed ID: 7405668
[No Abstract] [Full Text] [Related]
33. Dopamine and noradrenaline in post-mortem brain in Huntington's disease and schizophrenic illness.
Bird ED; Spokes EG; Iversen LL
Acta Psychiatr Scand Suppl; 1980; 280():63-73. PubMed ID: 6447433
[No Abstract] [Full Text] [Related]
34. Schizophrenia and dopamine receptors.
Seeman P
Eur Neuropsychopharmacol; 2013 Sep; 23(9):999-1009. PubMed ID: 23860356
[TBL] [Abstract][Full Text] [Related]
35. Interesting times for dopamine receptors.
Strange PG
Trends Neurosci; 1991 Feb; 14(2):43-5. PubMed ID: 1708534
[No Abstract] [Full Text] [Related]
36. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia.
Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL
Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577
[TBL] [Abstract][Full Text] [Related]
37. Study shows newer schizophrenia treatments no more effective than old.
Frantz S
Nat Rev Drug Discov; 2005 Nov; 4(11):872-3. PubMed ID: 16299914
[No Abstract] [Full Text] [Related]
38. Striatal dopamine receptors in rats displaying long-term behavioural sensitization to morphine.
Nestby P; Schotte A; Janssen PF; Tjon GH; Vanderschuren LJ; De Vries TJ; Mulder AH; Leysen JE; Schoffelmeer AN
Synapse; 1997 Nov; 27(3):262-5. PubMed ID: 9329160
[No Abstract] [Full Text] [Related]
39. Pathophysiology of schizophrenia: dopamine hypothesis.
Neylan TC
J Neuropsychiatry Clin Neurosci; 1996; 8(2):222. PubMed ID: 9081562
[No Abstract] [Full Text] [Related]
40. [Possible participation of limbic structures of the forebrain in the mechanism of the antipsychotic effect of neuroleptic preparations in schizophrenia (review)].
Aksent'ev SB; Mokhovikov AN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(8):1254-60. PubMed ID: 6137921
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
